Answers are grounded in this paper and cite their sources.
Background/Objectives: Growth in young children with IgE-mediated food allergy (FA) remains unclear, particularly whether deficits are present at diagnosis or emerge during follow-up. We compared growth at diagnosis and subsequent growth trajectories between children with FA and healthy controls. Methods: We retrospectively analyzed children younger than 6 years with IgE-mediated FA (n = 176) and healthy controls (n = 340), each with at least two anthropometric records, at a single center in Korea. Children with FA were matched 1:1 to controls by age and sex using propensity scores (149 pairs). Height, weight, and body mass index (BMI) standard deviation scores (SDS) were calculated using the 2017 Korean National Growth Charts and compared using linear mixed models stratified by age at the first measurement (<1 vs. ≥1 year). Results: Baseline SDS did not differ between groups. Height SDS declined faster in children with FA than in controls (−0.233 vs. −0.102 SDS/year; difference −0.131, 95% confidence interval −0.222 to −0.040; p = 0.005), with a significant between-group difference among children aged ≥1 year but not among those aged <1 year. Weight and BMI SDS trajectories did not differ between groups. In exploratory within-FA analyses, infants with an allergy to ≥2 foods showed steeper declines in height (difference −0.164 SDS/year; p = 0.044) and weight SDS (difference −0.263 SDS/year; p < 0.001) than infants allergic to egg or milk only. Conclusions: Despite comparable growth at diagnosis, children with IgE-mediated FA showed a steeper subsequent decline in height SDS. The clinical significance of this difference and the value of serial growth assessment or targeted nutritional management require prospective evaluation.
No takes yet. Share an insight, caveat, or question.
Kwon et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: